Rekah Pharmaceutical Industry Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
REKA
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 78.67M 6.27B | Sales 2023 | 322M 86.54M 6.9B | Capitalization | 169M 45.39M 3.62B |
---|---|---|---|---|---|
Net income 2022 | -2M -538K -42.92M | Net income 2023 | -6M -1.61M -129M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 39.12M 3.12B | Net Debt 2023 | 166M 44.78M 3.57B | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 23/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 31/10/18 |
Director/Board Member | 78 | 23/08/93 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 14/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 14/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 14/04/15 |
1st Jan change | Capi. | |
---|---|---|
+20.94% | 72.78B | |
-1.26% | 24.24B | |
+5.13% | 8.59B | |
+8.25% | 8.38B | |
-19.42% | 8.09B | |
+5.56% | 4.81B | |
+16.83% | 4.32B | |
-1.83% | 4.05B | |
-1.65% | 3.93B |